These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Amiodarone-induced thyrotoxicosis: a diagnostic and therapeutic challenge]. Schuetz P; Eriksson U; Christ-Crain M; Zulewski H; Miller B Praxis (Bern 1994); 2005 Sep; 94(36):1397-401. PubMed ID: 16190373 [TBL] [Abstract][Full Text] [Related]
9. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone]. Gómez JJ; Pomar MD; Casariego AV; Rodríguez IC Endocrinol Nutr; 2009 Oct; 56(8):418-21. PubMed ID: 19959152 [TBL] [Abstract][Full Text] [Related]
10. An adverse reaction to a medication given to treat an adverse reaction: a teachable moment. Rohrhoff NJ; McNeill DB; Boggan JC JAMA Intern Med; 2014 Jul; 174(7):1035-6. PubMed ID: 24841571 [No Abstract] [Full Text] [Related]
11. Amiodarone for the treatment of persistent atrial fibrillation. Noble SL; Replogle WH; Dickey SR J Fam Pract; 1999 May; 48(5):334-5. PubMed ID: 10334605 [No Abstract] [Full Text] [Related]
12. Fatal outcome during anaesthesia induction in a patient with amiodarone-induced thyrotoxicosis. Fideler FJ; Dieterich HJ; Schroeder TH Eur J Anaesthesiol; 2008 Apr; 25(4):337-9. PubMed ID: 18334037 [No Abstract] [Full Text] [Related]
13. Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Diamond TH; Rajagopal R; Ganda K; Manoharan A; Luk A Intern Med J; 2004 Jun; 34(6):369-70; author reply 370-1. PubMed ID: 15228405 [No Abstract] [Full Text] [Related]
14. Amiodarone-induced thyrotoxicosis: not a benign condition. Leung PM; Quinn ND; Belchetz PE Int J Clin Pract; 2002; 56(1):44-6. PubMed ID: 11831834 [TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]. Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034 [TBL] [Abstract][Full Text] [Related]
16. [Amiodarone: treatment or cause of atrial fibrillation?]. Allali G; Falconnet C Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735 [TBL] [Abstract][Full Text] [Related]
17. Paroxysmal atrial fibrillation precipitated by amiodarone-induced thyrotoxicosis five months after cessation of therapy. Schreiber DH; DeFreest MS J Emerg Med; 2006 Jul; 31(1):61-4. PubMed ID: 16798157 [TBL] [Abstract][Full Text] [Related]
18. Amiodarone for atrial fibrillation. Armon C N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561533 [No Abstract] [Full Text] [Related]
19. Amiodarone for atrial fibrillation. Skolnik N N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561532 [No Abstract] [Full Text] [Related]
20. Type II amiodarone-induced thyrotoxicosis and concomitant papillary cancer of the thyroid. Cattaneo F Eur J Endocrinol; 2000 Dec; 143(6):823-4. PubMed ID: 11124867 [No Abstract] [Full Text] [Related] [Next] [New Search]